Black Rock Inc. Immunocore Holdings PLC Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Black Rock Inc. holds 871,793 shares of IMCR stock, worth $29.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

871,793

Previous 867,357 0.51%

Holding current value

$29.8 Million

Previous $56.4 Million 47.59%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$33.78 - $63.75 $149,848 - $282,795	4,436 Added 0.51%	871,793 $29.5 Million
Q1 2024 May 10, 2024	BUY	$60.14 - $75.36 $5.31 Million - $6.66 Million	88,326 Added 11.34%	867,357 $56.4 Million
Q4 2023 Feb 13, 2024	BUY	$42.85 - $69.5 $822,634 - $1.33 Million	19,198 Added 2.53%	779,031 $53.2 Million
Q3 2023 Nov 13, 2023	SELL	$49.5 - $66.6 $1.6 Million - $2.15 Million	-32,251 Reduced 4.07%	759,833 $39.4 Million
Q2 2023 Aug 11, 2023	BUY	$48.54 - $61.64 $687,229 - $872,699	14,158 Added 1.82%	792,084 $47.5 Million
Q1 2023 May 12, 2023	SELL	$46.12 - $65.71 $510,502 - $727,343	-11,069 Reduced 1.4%	777,926 $38.5 Million
Q4 2022 Feb 13, 2023	BUY	$45.51 - $65.08 $13.2 Million - $18.8 Million	289,563 Added 57.98%	788,995 $45 Million
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $121,355 - $186,680	3,250 Added 0.66%	499,432 $23.4 Million
Q4 2021 Feb 10, 2022	SELL	$27.58 - $40.0 $9.14 Million - $13.3 Million	-331,422 Reduced 40.05%	496,182 $17 Million
Q3 2021 Nov 09, 2021	SELL	$27.98 - $40.0 $7.06 Million - $10.1 Million	-252,322 Reduced 23.36%	827,604 $30.7 Million
Q2 2021 Aug 11, 2021	BUY	$32.22 - $41.5 $34.8 Million - $44.8 Million	1,079,926 New	1,079,926 $42.2 Million

Others Institutions Holding IMCR

# of Institutions

146

Shares Held

45.1M

Call Options Held

297K

Put Options Held

1.17M

View Full List

About Immunocore Holdings plc

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.5B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

More about IMCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account